RxSight guides FY revenue above previous estimates, names new CFO
Source: SeekingAlpha
2026-01-12 02:22:02 ET
More on RxSight
- RxSight, Inc. (RXST) Q3 2025 Earnings Call Transcript
- RxSight down on CFO transition
- RxSight narrows 2025 revenue guidance to $125M–$130M while elevating gross margin outlook amid evolving commercial strategy
- Seeking Alpha’s Quant Rating on RxSight
- Historical earnings data for RxSight
Read the full article on Seeking Alpha
For further details see:
RxSight guides FY revenue above previous estimates, names new CFO
RxSight Inc.
NASDAQ: RXST
RXST Trading
-3.32% G/L:
$7.29 Last:
203,441 Volume:
$7.64 Open:
RXST Latest News
February 25, 2026 04:05:00 pm
RXSight, Inc. Reports Fourth Quarter and 2025 Results; Issues 2026 Guidance
February 11, 2026 04:10:00 pm
RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
RXST Stock Data
$337,567,614
37,181,778
N/A
47
N/A
Medical Equipment & Supplies
Healthcare
US
Aliso Viejo
